Metosartan CH 50 Tablet ER
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Chlorthalidone (12.5mg) + Metoprolol Succinate (50mg) + Telmisartan (40mg)
Overview Metosartan CH 50 Tablet ER
Extended-release Metosartan CH 50mg tablets are a combined medication employed to manage hypertension. This medication lowers blood pressure by promoting vasodilation and enhancing cardiac output. It also facilitates the excretion of excess fluid and certain electrolytes. Metosartan CH 50mg ER can be administered with or without food, but consistent timing optimizes therapeutic efficacy. Its diuretic effect may necessitate daytime dosing, at least four hours prior to sleep, to minimize nocturnal urination. Dosage and frequency are determined by your physician, based on individual needs and therapeutic goals. Continuous use, as directed, is crucial. Commonly reported adverse effects include nausea, altered taste perception, diarrhea, and gastrointestinal discomfort. Regular monitoring of renal function and electrolyte levels is essential. Optimal outcomes are achieved through concomitant lifestyle modifications, including balanced nutrition, regular physical activity, and smoking cessation. Increased fluid intake is advised to counteract potential dryness of the mouth or thirst. Prior to initiating treatment, inform your physician of any pregnancy, circulatory disorders, liver or kidney disease, or other medications you are currently using, as drug interactions can impact efficacy or alter the medication's effects.
Primary Ingredients of Metosartan CH 50 Tablet ER
No text provided to rephrase.
Uses of Metosartan CH 50 Tablet ER
Elevated arterial blood pressure
Major Benefits of Metosartan CH 50 Tablet ER:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the Metosartan CH 50 Tablet ER whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable; however, consistent daily timing is recommended.
Common Side effects of Metosartan CH 50 Tablet ER:
- Nausea
- Taste change
- Diarrhea
- Upset stomach
- Headache
- Dizziness
- Weakness
- Cold extremities
- Numbness of extremity
- Increased uric acid level in blood
- Increased blood lipid level
- Decreased magnesium level in blood
- Slow heart rate
- Decreased sodium level in blood
- Decreased blood pressure
How to use Metosartan CH 50 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Metosartan CH 50 Tablet ER whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, but consistency in timing is recommended.
How Metosartan CH 50 Tablet ER works:
Telmisartan, metoprolol succinate, and chlorthalidone—the three active components in Metosartan CH 50 ER tablets—work synergistically to reduce high blood pressure.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Metosartan CH 50 Tablet ER is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Use of Metosartan CH 50 Tablet ER is contraindicated during pregnancy due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician may prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release metoprolol succinate 50 mg tablets (Metosartan CH 50 Tablet ER) are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release metoprolol succinate 50 mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
For individuals with severe kidney impairment, the extended-release Metosartan CH 50 mg tablet requires careful administration and may necessitate dosage modification. Physician consultation is advised. This medication is generally unsuitable for such patients.
LiverCAUTION
Patients with liver impairment should take Metosartan CH 50 Tablet ER cautiously, potentially requiring a modified dosage. Physician consultation is advised. Metosartan CH 50 Tablet ER is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Metosartan CH 50 Tablet ER :
Should you forget to take a Metosartan CH 50 Tablet ER, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metosartan CH 50 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | HEART |



